[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 3 sources · 3 days · First seen · Last updated

Corporate executive insider stock sales

Overview

In early August 2026, several corporate executives and insiders engaged in significant stock sales, as documented in regulatory filings.

Initial reports highlighted large divestments by leadership at Tower Semiconductor and Encompass Health. Tower Semiconductor CEO Russell Craig Ellwanger sold approximately $25.88 million in shares, reducing his ownership by 16.52%, while Encompass Health CEO Mark Tarr sold roughly $21.72 million in shares, a 39.27% decrease in his position. Other notable sales involved executives from AMETEK, EverQuote, and Everus Construction Group.

Subsequent filings showed further insider activity, including Rhythm Pharmaceuticals Executive Vice President Yann Mazabraud, who sold 57,000 shares for approximately $6.62 million under a pre-arranged trading plan. Additionally, Hannah Rothschild sold 24,365 shares of the London-based investment trust RIT Capital Partners for approximately £633,490.

Entities

EverQuote, Inc. · Alistair Sporck · Rhythm Pharmaceuticals, Inc. · Tower Semiconductor Ltd. · Aehr Test Systems

Timeline

  1. 11 days ago

    [BUSINESS] 2 sources
    Executives at Rhythm Pharmaceuticals and RIT Capital Partners sell shares

    Executives at Rhythm Pharmaceuticals and RIT Capital Partners have conducted significant insider stock sales in August.

  2. 13 days ago

    [BUSINESS] 3 sources
    Corporate executives execute significant insider stock sales

    Multiple corporate executives, including CEOs of Tower Semiconductor and Encompass Health, have reported significant insider stock sales in SEC filings during August.

Sources

mommygearest.com · seekingalpha.com · stocknews.com